• Users Online: 6969
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Exendin-4 for Parkinson's disease

Esparza-Salazar Felipe de Jesús, Lezama-Toledo Alma Rosa, Rivera-Monroy Germán, Borlongan Cesario V

Year : 2021| Volume: 7| Issue : 1 | Page no: 41-43

   This article has been cited by
1 Dipeptidyl peptidase 4(DPP4) inhibitors stride up the management of Parkinson's disease
Maanvi, Shilpa Kumari, Rahul Deshmukh
European Journal of Pharmacology. 2022; : 175426
[Pubmed]  [Google Scholar] [DOI]
2 Glucagon-Like Peptide-1 Receptor Agonists as Potential Myelination-Inducible and Anti-Demyelinating Remedies
Kazunori Sango, Shizuka Takaku, Masami Tsukamoto, Naoko Niimi, Hideji Yako
Frontiers in Cell and Developmental Biology. 2022; 10
[Pubmed]  [Google Scholar] [DOI]
3 Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
Yolanda Diz-Chaves, Zainab Mastoor, Carlos Spuch, Lucas C. González-Matías, Federico Mallo
International Journal of Molecular Sciences. 2022; 23(17): 9583
[Pubmed]  [Google Scholar] [DOI]
4 The Neuroprotective Effect of NEUROMIDE, a Compound Bioidentical to Commensal Bacteria Metabolites
Yoonhee Seo, Hyunji Tak, Dohee Park, Hyejin Song, Sooyoung Choe, Chaehyeong Park, Byeongdeog Park
Life. 2022; 12(10): 1529
[Pubmed]  [Google Scholar] [DOI]


Read this article